跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SODIUM IODIDE I-123 ORAL SOLUTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SODIUM IODIDE I-123 ORAL SOLUTION
Authorized
STANDARD
SODIUM IODIDE I-123 ORAL SOLUTION
BWXT Medical Ltd
🇨🇦 Health Canada
Approval Date
Feb 5, 2026
Approval ID
23b670a30fde96eb
Company
BWXT Medical Ltd
Type
Standard
Approval Details
Approval Id
23b670a30fde96eb
Drug Approval Canada Name
SODIUM IODIDE I-123 ORAL SOLUTION
Product Name
SODIUM IODIDE I-123 ORAL SOLUTION
Status
Marketed
Din
02478366
Drug Class
Radiopharmaceutical
Dosage Form
Solution
Route Of Administration
Oral
Schedule
Schedule C
Ahfs
78:00.00
Atc Original
V09FX02 SODIUNM IODIDE 123 I
Aig Number
0152609005
Company Name
BWXT Medical Ltd
Company Address
447 March Road Ottawa Ontario Canada K2K 1X8
Company Detail Path
/organization/bwxt-medical-ltd
Company Information
Pharmaceutical Company Name
BWXT Medical Ltd
Country Name
Canada
Province Name
Ontario
City Name
cambridge,ontario,country_ca
Address
581 Coronation Blvd
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Feb 5, 2026
Approval ID
23b670a30fde96eb
Type
Standard
Back to Health Canada Approvals